Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study

INTRODUCTION: To evaluate the effects of efpeglenatide, a long-acting glucagon-like peptide-1 receptor agonist (GLP-1 RA), on gastric emptying, glucose metabolism, and islet beta-cell function versus liraglutide and placebo in people with type 2 diabetes. RESEARCH DESIGN AND METHODS: This phase Ib s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hompesch, Marcus, Kang, Jahoon, Han, OakPil, Trautmann, Michael E, Sorli, Christopher H, Ogbaa, Ike, Stewart, John, Morrow, Linda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immunology and Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237726/
https://www.ncbi.nlm.nih.gov/pubmed/34172436
http://dx.doi.org/10.1136/bmjdrc-2021-002208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237726/
https://www.ncbi.nlm.nih.gov/pubmed/34172436
http://dx.doi.org/10.1136/bmjdrc-2021-002208

Ejemplares similares